Nuvectis Pharma (NVCT) Institutional Ownership → Elon to Transform U.S. Economy? (From Porter & Company) (Ad) Free NVCT Stock Alerts $6.53 -0.12 (-1.80%) (As of 05/16/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Nuvectis Pharma (NASDAQ:NVCT)CurrentInstitutional OwnershipPercentage96.77%Number ofInstitutional Buyers(last 12 months)9TotalInstitutional Inflows(last 12 months)$2.27MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$1.28M Get NVCT Insider Trade Alerts Want to know when executives and insiders are buying or selling Nuvectis Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data NVCT Institutional Buying and Selling by Quarter Ad Behind the MarketsInvest in the "Trojan Horse" of Alzheimer's TreatmentThis one tiny Micro-Cap is at the forefront of what may be the most significant development in healthcare since the discovery of antibiotics.Click here and learn how you can invest in this incredible opportunity>>> Nuvectis Pharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/10/2024 Vanguard Group Inc.298,800$2.45M0.0%+1.5%1.626% 4/18/2024 Blue Zone Wealth Advisors LLC14,350$118K0.0%N/A0.081% 2/12/2024 Edmond DE Rothschild Holding S.A.19,170$160K0.0%N/A0.111% 1/30/2024 Strs Ohio6,200$51K0.0%+59.0%0.036% 1/8/2024 Baldwin Brothers LLC MA142,040$1.19M0.1%+22.0%0.820% 11/2/2023 Forbes J M & Co. LLP34,000$438K0.1%-49.3%0.197% 10/26/2023 Strs Ohio3,900$50K0.0%+178.6%0.023% 10/10/2023 Baldwin Brothers LLC MA116,380$1.50M0.1%+29.2%0.675% 8/10/2023 Hollencrest Capital Management3,040$49K0.0%N/A0.019% 8/4/2023 American International Group Inc.3,298$53K0.0%N/A0.021% 8/3/2023 Forbes J M & Co. LLP67,000$1.07M0.1%N/A0.418% 8/2/2023 Bank of Montreal Can11,012$200K0.0%N/A0.069% 7/14/2023 Baldwin Brothers LLC MA90,061$1.44M0.1%-37.4%0.563% 5/11/2023 Edmond DE Rothschild Holding S.A.24,570$322K0.0%N/A0.167% 4/21/2023 Baldwin Brothers LLC MA143,800$1.89M0.2%+7.9%0.975% 11/4/2022Ronit Capital LLP562,547$3.99M5.4%+34.2%3.843% 10/14/2022 Baldwin Brothers LLC MA133,000$943K0.1%+9.9%0.908% 8/4/2022Ronit Capital LLP419,282$4.70M6.7%-23.8%3.297% 7/18/2022 Baldwin Brothers LLC MA121,000$1.36M0.2%N/A0.951% 5/11/2022Ronit Capital LLP550,000$4.08M5.1%N/A4.325% (Data available from 1/1/2016 forward) NVCT Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of NVCT shares? During the previous two years, 10 institutional investors and hedge funds held shares of Nuvectis Pharma. The most heavily invested institutionals were Ronit Capital LLP ($3.99M), Vanguard Group Inc. ($2.45M), Baldwin Brothers LLC MA ($1.19M), Forbes J M & Co. LLP ($438K), Bank of Montreal Can ($200K), Edmond DE Rothschild Holding S.A. ($160K), and Blue Zone Wealth Advisors LLC ($118K).Learn more on NVCT's institutional investors. What percentage of Nuvectis Pharma stock is owned by institutional investors? 96.77% of Nuvectis Pharma stock is owned by institutional investors. Learn more on NVCT's institutional investor holdings. Which institutional investors have been buying Nuvectis Pharma stock? Of the 10 institutional investors that purchased Nuvectis Pharma stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Baldwin Brothers LLC MA ($195.48K), Ronit Capital LLP ($143.27K), Forbes J M & Co. LLP ($67K), Edmond DE Rothschild Holding S.A. ($43.74K), Blue Zone Wealth Advisors LLC ($14.35K), Bank of Montreal Can ($11.01K), and Strs Ohio ($4.80K). How much institutional buying is happening at Nuvectis Pharma? Institutional investors have bought a total of 490,501 shares in the last 24 months. This purchase volume represents approximately $5.18M in transactions. Which Nuvectis Pharma major shareholders have been selling company stock? The following institutional investors have sold Nuvectis Pharma stock in the last 24 months: Ronit Capital LLP ($130.72K), Baldwin Brothers LLC MA ($53.74K), and Forbes J M & Co. LLP ($33K). How much institutional selling is happening at Nuvectis Pharma? Institutional investors have sold a total of 217,457 shares in the last 24 months. This volume of shares sold represents approximately $2.75M in transactions. Related Companies: VTGN Major Shareholders AMLX Major Shareholders DMAC Major Shareholders OPTN Major Shareholders COYA Major Shareholders CNTX Major Shareholders KPTI Major Shareholders PDSB Major Shareholders FGEN Major Shareholders ADAG Major Shareholders This page (NASDAQ:NVCT) was last updated on 5/17/2024 by MarketBeat.com Staff From Our PartnersCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceInvest in the "Trojan Horse" of Alzheimer's TreatmentBehind the Markets348 million Americans lives to END as we know it?The Oxford ClubGold Set to EXPLODE!Gold Safe Exchange[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsHow Biden has already won 2024Porter & CompanyA once-in-a-century investment opportunityStansberry ResearchCharles Payne Demystifies OptionsUnstoppable Prosperity Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nuvectis Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
